Gradient Biotech
U

Menu

Welcome

The Oncology area of Gradient Biotech is a web workspace for multi-omic, spatial, and clinical oncology research. It builds on the Computational Biology foundation — single-cell, spatial, bulk RNA-seq, and biomarker pipelines — and extends it with oncology-specific capabilities: cell-cell communication, immune profiling, mutation landscape analysis, and clinical outcome integration.

What you can do today

CapabilityStatus
Study and cohort managementTumor type, stage, treatment arm, response status, sample metadata
Clinical endpointsSurvival, recurrence, and response records linked to patients
Mutation datasetsMAF/VCF ingestion records with per-sample variant tables
Repertoire datasetsTCR/BCR sequencing file records for clonotype analysis
Tumor microenvironmentTME composition view (calls compbio single-cell infrastructure)
Cell-cell communicationLigand-receptor scoring, pathway aggregation, condition comparison
Immuno-oncology profilingDeconvolution, TIDE-like phenotype, exhaustion, repertoire metrics
Mutation landscapeTMB, signatures, oncoprint, copy number, driver pathway enrichment
Survival analysisKaplan-Meier, log-rank testing, Cox regression, longitudinal trajectories
AI interpretationGrounded summaries for communication, immune, mutation, and survival outputs
Run historyStudy-level pipeline run tracking with artifact links

How the product is organized

Every analysis lives inside a study — your oncology project container. From the oncology dashboard you create or open a study, then work through:

  1. Overview — study metadata, workflow cards, and run history
  2. Data — samples, clinical endpoints, mutation and repertoire datasets
  3. TME — tumor microenvironment composition (compbio-backed)
  4. Communication — ligand-receptor and signaling network analysis
  5. Immune — deconvolution, immune phenotype, exhaustion, and repertoire profiling
  6. Mutations — somatic mutation landscape and oncoprint summaries
  7. Survival — clinical endpoint analysis stratified by molecular features
  8. Interpret — AI-assisted summaries grounded in completed pipeline outputs

Pipeline jobs run asynchronously. Launch jobs from workflow pages and refresh when complete.

Who this is for

  • Tumor biology researchers studying cell-cell communication, spatial TME mapping, and immune infiltration
  • Translational oncology teams correlating mutation landscapes with therapy response and survival
  • Immuno-oncology researchers profiling exhaustion states, repertoire diversity, and IO response phenotypes
  • Computational oncology groups running reproducible multi-omic pipelines with full provenance

What this is not

  • Not a regulated clinical diagnostic or clinical decision support tool
  • Not a replacement for established algorithms — it orchestrates and modernizes them
  • Not a standalone single-modality tool — value compounds as more data types connect within a study

Next steps

  • Use cases — scenario guides for IO response, mutation-outcome, TME signaling, and multi-omic integration
  • Quick start — create a study and run your first oncology pipeline
  • Key concepts — studies, samples, runs, and artifacts
  • Study workflow — how the main sections fit together